<DOC>
	<DOCNO>NCT02853071</DOCNO>
	<brief_summary>This study evaluate efficacy , safety quality life patient affect metastatic breast cancer RH+/ HER2- treat estramustine phosphate .</brief_summary>
	<brief_title>Efficacy Safety Estracyt® Metastatic Breast Cancer</brief_title>
	<detailed_description>For patient affected metastatic breast cancer RH+/HER2- , conventional treatment hormonotherapy . But , patient n't react recommendation exist . Estramustine phosphate currently prescribe prostate cancer . The estramustine phosphate active anti-tumoral agent oral route , associate nitrogenous mustard estradiol , settle membrane receptor cytotoxic component act essentially dismantle microtubule inhibit mitosis . Estramustine could therapeutic option currently therapy exhaust patient reactive hormonotherapy previous line chemotherapy .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Estramustine</mesh_term>
	<criteria>Metastatic breast cancer HER2/RH+ Progression hormonotherapy Treated taxanes , anthracyclines , capecitabine eribulin Treated everolimus ECOG ≤ 2 Hematological Function : neutrophile ≥ 1,5 x 109 / L , hemoglobin ≥ 9 g / dL , plaque ≥ 100 x 109 / L Hepatic function : albumin ≥ 2,5 g / dl , bilirubin serum ≤ 2 x N ( superior border standard ) ( unless disease Gilbert ) , transaminases ≥ 3 x N Renal Function : serum creatinine ≤ 1,5 mg / dL clearance creatinine ≥ 40 mL / min Estimated Life expectancy ≥ 3 month Hypersensitivity know one constituent estramustine phosphate Preliminary Treatment estramustine phosphates Brain Metastases Patients effective contraception Minor , pregnant lactating Patients Patients previously treat everolimus Transaminases &gt; 3xN Other concomitant anticancer treatment le 1 month inclusion Digestive function : malabsorption History cancer previous 5 year ( squamouscell epithelioma totally resected situ carcinoma ) Active Thrombophlebitis Risk thromboembolic know , Unchecked cardiovascular Pathology Grave hepatic Affection</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>